Thank you for your interest in Molecular Medicine. The journal has recently switched publishers to BMC, who will host all back content. If you notice any missing content, please reach out to us.
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume ...
Citation: Molecular Medicine 2019 25:30